SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: Kenneth M. Koff, CPCU who wrote (376)3/10/1999 11:33:00 PM
From: 5,17,37,5,101,...  Read Replies (1) | Respond to of 2515
 
Thanks Ken,

I agree. My last stock on CNBC was IDTI at $12! Greater than 50% decline since. CEO looked like crap. But then again, IMCL people have always been softspoken and drugs really are winners. The news on CNBC is almost surely going to be no news to me or anyone really. IMCL is approaching full valuation ($20-$25) which of course means nothing to investors. Hang on for $12.00 again or $30.00; your guess is as good as mine. With only 25MILL outstanding somebody bought/sold an awful lot of shares today or it was a few people churning. Hmmm...who might want to do that?

Jackson



To: Kenneth M. Koff, CPCU who wrote (376)3/11/1999 1:36:00 AM
From: av8r  Read Replies (1) | Respond to of 2515
 
Kenneth,

I think Maria would be coaching the CEO prior to his being on CNBC so as NOT to look like so many that have gone before him. In fact, I think he may come off quite polished with her help. See:

exchange2000.com

I would expect a bump up after this interview.

JMHO


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News